Response

Affiliations

¹ Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China. Electronic address: kyyuen@hkucc.hku.hk.

Comment

Ivan F N Hung et al. Chest. 2018 Oct.

. 2018 Oct;154(4):999.

doi: 10.1016/j.chest.2018.07.022.

¹ Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China. Electronic address: kyyuen@hkucc.hku.hk.

No abstract available

Comment on

Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang AJ, Li P, Wong TL, Zhang R, Cheung MKS, Leung W, Lau JYN, Fok M, Chen H, Chan KH, Yuen KY. Hung IFN, et al. Chest. 2017 May;151(5):1069-1080. doi: 10.1016/j.chest.2016.11.012. Epub 2016 Nov 22. Chest. 2017. PMID: 27884765 Clinical Trial.
Outcome Switching in Triple Therapy in Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Mazzetti A, Neary JD. Mazzetti A, et al. Chest. 2018 Oct;154(4):998-999. doi: 10.1016/j.chest.2018.07.021. Chest. 2018. PMID: 30290948 No abstract available.